Tetsuyo Maeda

449 total citations
26 papers, 341 citations indexed

About

Tetsuyo Maeda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biological Psychiatry. According to data from OpenAlex, Tetsuyo Maeda has authored 26 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Biological Psychiatry. Recurrent topics in Tetsuyo Maeda's work include Cancer-related cognitive impairment studies (5 papers), Tryptophan and brain disorders (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Tetsuyo Maeda is often cited by papers focused on Cancer-related cognitive impairment studies (5 papers), Tryptophan and brain disorders (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Tetsuyo Maeda collaborates with scholars based in Japan, Russia and United States. Tetsuyo Maeda's co-authors include T. Kawamata, Y. Katayama, Tatsuro Mori, Sadao Amano, Kenichi Sakurai, Katsuhisa Enomoto, Yoko Nakanishi, T. Tsubokawa, Norimichi Nemoto and Takahiro Suzuki and has published in prestigious journals such as Cancer Research, Brain Research and Toxicology.

In The Last Decade

Tetsuyo Maeda

25 papers receiving 339 citations

Peers

Tetsuyo Maeda
Zhihuang Zheng China
Sanpeng Xu China
Ryan Stuchbery Australia
Matthew A.M. Devall United States
Egidius H.J. Heerkens United Kingdom
Yu‐Ping Liao China
Jingjing Liang China
Ruili Wang China
Yoshiaki Fujii Japan
Zhihuang Zheng China
Tetsuyo Maeda
Citations per year, relative to Tetsuyo Maeda Tetsuyo Maeda (= 1×) peers Zhihuang Zheng

Countries citing papers authored by Tetsuyo Maeda

Since Specialization
Citations

This map shows the geographic impact of Tetsuyo Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuyo Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuyo Maeda more than expected).

Fields of papers citing papers by Tetsuyo Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuyo Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuyo Maeda. The network helps show where Tetsuyo Maeda may publish in the future.

Co-authorship network of co-authors of Tetsuyo Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuyo Maeda. A scholar is included among the top collaborators of Tetsuyo Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuyo Maeda. Tetsuyo Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosonaga, Mari, Takeshi Nakajima, Ippei Fukada, et al.. (2024). Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers. Breast Cancer. 31(5). 988–996. 1 indexed citations
2.
3.
Fujishima, Makoto, Makiko Ono, Jun Masuda, et al.. (2022). Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer. Breast Cancer Research and Treatment. 196(2). 341–348. 14 indexed citations
4.
5.
Masaki, Chie, Kiminori Sugino, Naoko Saito, et al.. (2017). Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma. Endocrine Journal. 64(8). 819–826. 31 indexed citations
6.
Sakurai, Kenichi, et al.. (2015). A Case of Non-invasive Ductal Carcinoma of the Male Breast with a Pagetoid-like Carcinoma Formation. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 76(5). 961–964.
7.
Maeda, Tetsuyo, Yoko Nakanishi, Katsuhisa Enomoto, et al.. (2015). Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer. Medical Molecular Morphology. 49(1). 11–21. 42 indexed citations
8.
Yamamoto, Shin‐ichi, et al.. (2015). Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose–response study. Acta Anaesthesiologica Scandinavica. 59(7). 892–901. 16 indexed citations
9.
Sakurai, Kenichi, et al.. (2013). [Long-term response to eribulin in patients with metastatic breast cancer-report of 2 cases].. PubMed. 40(12). 2372–4. 1 indexed citations
10.
Sakurai, Kenichi, Shigeru Fujisaki, Tetsuyo Maeda, et al.. (2013). [Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery].. PubMed. 40(12). 1590–2. 5 indexed citations
11.
Sakurai, Kenichi, Shigeru Fujisaki, Tetsuyo Maeda, et al.. (2013). [Indoleamine 2, 3-dioxygenase activity during neoadjuvant chemotherapy in patients with breast cancer].. PubMed. 40(12). 1578–80. 2 indexed citations
12.
Sakurai, Kenichi, Shigeru Fujisaki, Tetsuyo Maeda, et al.. (2012). [Analysis of indoleamine 2, 3-dioxygenase expression in breast cancer patients with bone metastasis].. PubMed. 39(12). 1776–8. 9 indexed citations
13.
Sakurai, Kenichi, Shigeru Fujisaki, Masahiko Shibata, et al.. (2011). [Long-term follow-up study: indolemamine 2,3-dioxygenase activity during chemotherapy or hormone therapy in patients with breast cancer].. PubMed. 38(12). 1930–2. 2 indexed citations
14.
Sakurai, Kenichi, Shigeru Fujisaki, Masahiko Shibata, et al.. (2011). [Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer].. PubMed. 38(12). 1927–9. 4 indexed citations
15.
Uno, Shigeyuki, Mihwa Choi, Tetsuyo Maeda, et al.. (2010). Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice. Toxicology. 280(1-2). 10–17. 24 indexed citations
16.
Katayama, Y., et al.. (2006). Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta neurochirurgica. Supplementum. 96. 130–133. 134 indexed citations
17.
18.
Katayama, Y., T. Kawamata, Tetsuyo Maeda, Koichi Ishikawa, & T. Tsubokawa. (1994). Inhibition of the early phase of free fatty liberation during cerebral ischemia by excitatory amino acid antagonist administered. Brain Research. 635(1-2). 331–334. 13 indexed citations
19.
Kawamata, T., et al.. (1994). Free Fatty Acid Liberation and Cellular Swelling During Cerebral Ischemia: the Role of Excitatory Amino Acids. PubMed. 60. 242–245. 10 indexed citations
20.
Morimoto, Shinichi, Yoichi Hiasa, Tetsuyo Maeda, et al.. (1986). [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].. PubMed. 34(11). 1221–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhihuang Zheng Breakdown of academic impact, for papers by Sanpeng Xu Breakdown of academic impact, for papers by Ryan Stuchbery Breakdown of academic impact, for papers by Matthew A.M. Devall Breakdown of academic impact, for papers by Egidius H.J. Heerkens Breakdown of academic impact, for papers by Yu‐Ping Liao Breakdown of academic impact, for papers by Jingjing Liang Breakdown of academic impact, for papers by Ruili Wang Breakdown of academic impact, for papers by Yoshiaki Fujii
Rankless by CCL
2026